Chen Xiaofei, Wu Haitang, Cao Yan, Yao Xiangwen, Zhao Liang, Wang Tianqi, Yang Yu, Lv Diya, Chai Yifeng, Cao Yingying, Zhu Zhenyu
Second Military Medical University School of Pharmacy, Shanghai 200433, China.
Mol Biosyst. 2014 Jan;10(1):74-85. doi: 10.1039/c3mb70240e. Epub 2013 Oct 23.
Candida albicans, the most common fungal pathogen related to colonization and biofilm formation on the surfaces of indwelling medical devices, shows high resistance to the most commonly used antifungal drugs. In this study, an ion-pairing chromatography-porous graphitic carbon column coupled with a time-of-flight mass spectrometry (IP-PGC-TOF/MS) system was developed for targeted and untargeted profiling of metabolites involved in biofilm and planktonic growth of C. albicans. Using untargeted profiling analysis, 16 differential metabolites were screened and identified as potential biomarkers, most of which were amino acids or related compounds. Based on untargeted profiling analysis, targeted quantitative analysis of 22 amino acids was established and carefully evaluated using stable isotope-labeled internal standards. Among them, 9 amino acids that were not screened by untargeted profiling were further characterized as new biomarkers. Finally, a total of 25 potential biomarkers were screened using the combined targeted and untargeted strategy, among which 16 were characterized for the first time. Our results confirmed that amino acid metabolism and polyamine metabolism were at a high level in biofilms, except for some new biomarkers including ornithine, arginine and proline that were directly related to ornithine. Further experiments were carried out on the ornithine decarboxylase-negative (spe1Δ) mutant, and the results showed that the consumption of ornithine for putrescine biosynthesis has a significant impact on biofilm formation and may prove to be a drug target for resolving drug resistance of C. albicans. This study provides a systematic view of changes in amino acid metabolism during C. albicans biofilm formation by a combination of targeted and untargeted profiling using an original IP-PGC-TOF/MS method. It is a feasible approach for characterizing subtle variations and screening novel biomarkers from the microbial metabolome.
白色念珠菌是与留置医疗器械表面定植和生物膜形成相关的最常见真菌病原体,对最常用的抗真菌药物表现出高度抗性。在本研究中,开发了一种离子对色谱 - 多孔石墨化碳柱与飞行时间质谱(IP-PGC-TOF/MS)联用系统,用于对白色念珠菌生物膜和浮游生长中涉及的代谢物进行靶向和非靶向分析。通过非靶向分析,筛选并鉴定出16种差异代谢物作为潜在生物标志物,其中大多数是氨基酸或相关化合物。基于非靶向分析,建立了22种氨基酸的靶向定量分析方法,并使用稳定同位素标记的内标进行了仔细评估。其中,9种未通过非靶向分析筛选出的氨基酸被进一步鉴定为新的生物标志物。最后,使用靶向和非靶向相结合的策略共筛选出25种潜在生物标志物,其中16种是首次鉴定。我们的结果证实,除了一些与鸟氨酸直接相关的新生物标志物(包括鸟氨酸、精氨酸和脯氨酸)外,生物膜中的氨基酸代谢和多胺代谢处于高水平。对鸟氨酸脱羧酶阴性(spe1Δ)突变体进行了进一步实验,结果表明鸟氨酸用于腐胺生物合成的消耗对生物膜形成有显著影响,可能被证明是解决白色念珠菌耐药性的药物靶点。本研究通过使用原创的IP-PGC-TOF/MS方法结合靶向和非靶向分析,提供了白色念珠菌生物膜形成过程中氨基酸代谢变化的系统观点。这是一种从微生物代谢组中表征细微变化和筛选新型生物标志物的可行方法。